![]() ![]() It takes the form of a simple questionnaire and is considered to give an informative expression of the general status of the patient in domains of major importance to people with RA. To assess this impact, an international collaboration between people with RA, rheumatologists and healthcare professionals under the aegis of the European League Against Rheumatism developed the RAID. Ferreira et al 4 5 proposed two different targets in the management of RA: disease process remission and disease impact control. 1–3 An important proportion of patients with RA with complete control of the inflammatory process still perceive significant impact of the disease, which is missed by objective clinical evaluation through physical examination and biomarkers. The Rheumatoid Arthritis Impact of Disease (RAID) score is a patient-reported outcome measure (PROM) for evaluating the impact of rheumatoid arthritis (RA) on patient quality of life it also indicates disease activity from the patient’s perspective. This supports the use of RAID for measuring the impact also of other rheumatic diseases. The RAID score performs comparably across all diagnoses investigated. Linear regression revealed no clinically relevant effect of any of the diagnoses on the difference between RAID and the other outcomes. Discrepancies between other scores and RAID were comparable to RA. Mean differences were calculated for RAID and PtGl disease activity (0 to −0.6), PtGl health (−0.4 to −0.9), WHO-5 (−0.7 to −1.3), EQ-5D (1.1 to 1.7) and PhGl disease activity (1.4 to 2.2). ![]() The effect of each diagnosis on the difference between RAID and the other scores was assessed with linear regression, with RA as the reference.Īcross all diagnoses, RAID correlated strongly with PtGl health (0.71–0.83), moderately to strongly with PtGl disease activity (0.59–0.79), WHO-5 (0.65–0.81) and EQ-5D (0.68–0.73) and weakly with PhGl disease activity (0.23–0.38). As a measure of agreement, the mean differences between the RAID and other outcomes were compared with the respective differences for RA. For each diagnosis, we calculated age-adjusted/sex-adjusted partial correlation coefficients between RAID and patient global (PtGl) health, PtGl disease activity, physician global (PhGl) disease activity, Well-Being Index (WHO-5) and EuroQoL-5 Dimensions (EQ-5D). To analyse the performance of the rheumatoid arthritis impact of disease (RAID) score in patients with ankylosing spondylitis, polymyalgia rheumatica, systemic lupus erythematosus, primary Sjögren’s syndrome, idiopathic inflammatory myositis and systemic sclerosis, as compared with rheumatoid arthritis (RA).Ī total of 12 398 patients from the German National Database were included. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
March 2023
Categories |